latest news releases from the newsroom
Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation Announces Intent to File Form 10
KENNEWICK, Wash., Aug. 1, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets: ADMD) (http:www.isotopeworld.com) announced that it is preparing to file a registration statement on Form 10 with the Securities and Exchange Commission ("SEC"). Advanced Medical recently completed an audit of its financial statements and has engaged Sichenzia Ross Friedman Ference ("SRFF") to prepare its Form 10. After the Form 10 is filed and becomes effective, AMIC will become a public reporting company and will be required to file annual, quarterly and current reports as well as other information with the SEC.
Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant
PHILADELPHIA, Pa., Aug. 1, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it has signed a license and supply agreement with Daewoong Pharmaceuticals Co. Ltd, a leading South Korean pharmaceutical company. Under terms of the agreement, Daewoong will commercialize, subject to regulatory approval, Eurand's novel extended-release (ER) formulation of the muscle relaxant Cyclobenzaprine HCl in South Korea. Cyclobenzaprine ER has been developed using Eurand's innovative Diffucaps(r) technology. Financial terms were not disclosed.
EMS Technologies, Inc.
EMS Technologies Appoints Neil Mackay Chief Operating Officer and EVP
ATLANTA, Aug. 1, 2008 (PRIME NEWSWIRE) -- EMS Technologies, Inc. (Nasdaq:ELMG) announced today the appointment of Dr. Neil Mackay as Chief Operating Officer and Executive Vice President for EMS Technologies, Inc., reporting to EMS President and CEO, Paul Domorski.